Stay Updated with the Latest Uni Abex Alloy Products Limited UNIABEXAL.BO News in Real Time
Find UNIABEXAL.BO news now at Meyka AI. Stay informed with the latest Uni Abex Alloy Products Limited stocks updates, including price news, market analysis, and expert insights.
SpaceX Shares Fall More Than 5% Premarket, Extending Post-IPO Pullback After Record Rally
SpaceX shares came under pressure on June 22, 2026, falling more than 5% in premarket trading after an extraordinary post-IPO rally that captured Wall Street’s attention. The stock had surged to record highs in the days following its market debut, pushing the company’s valuation to unprecedented levels. Now, investors are weighing whether the recent decline…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…
CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA
CRH made its biggest-ever acquisition official on June 22, 2026, signing a definitive agreement to acquire Arcosa, Inc. (NYSE: ACA) in an all-cash transaction. CRH will pay $150 per share in cash, with the transaction valuing Arcosa at a total enterprise value of approximately $8.5 billion, representing an acquisition multiple of 11.5x 2026E Adjusted EBITDA,…
Huawei’s CloudMatrix Cluster Achieves 30% Utilization After Training DeepSeek’s 1.6-Trillion-Parameter AI Model
Huawei’s AI ambitions reached a new milestone in June 2026 when reports revealed that its CloudMatrix cluster achieved 30% utilization while post-training DeepSeek V4-Pro, a massive 1.6-trillion-parameter AI model. The achievement highlights the growing capabilities of Huawei’s Ascend chip ecosystem at a time when global competition in artificial intelligence infrastructure is intensifying. As China pushes…
Starmer Resigns: Pound Falls 0.4% Near 2026 Low as GBP/USD Slips to $1.3181
The British pound came under fresh pressure on June 22, 2026, after Prime Minister Keir Starmer announced his resignation, triggering uncertainty across UK financial markets. Sterling fell 0.4% against the US dollar, slipping to around $1.3181 and moving close to its lowest level of the year. Investors are now assessing what a leadership change could…
FTSE 100 Dips 0.07% as Political Concerns Return Despite Improved Sentiment on Hormuz Talks
The FTSE 100 edged lower on Monday as investors balanced improving news from the Middle East with renewed political uncertainty in the United Kingdom. While hopes of progress in talks over the reopening of the Strait of Hormuz helped reduce pressure on oil prices, concerns over the UK’s political outlook kept buyers cautious. The benchmark…
RVNL (NSE: RVNL) Shares Rise 3% After Winning ₹2,977 Crore NMDC Contract for Vizag Infrastructure Project
Rail Vikas Nigam Limited (RVNL) is back in the spotlight after securing a massive ₹2,977 crore contract from NMDC for a key infrastructure project in Visakhapatnam. The announcement pushed RVNL shares nearly 3% higher, reflecting strong investor confidence in the company’s expanding project pipeline. As India continues to invest heavily in transport and industrial infrastructure,…
Voltas Shares (NSE: VOLTAS) Surge 3.89% as AC Sales Cross 1 Million Mark in Record Q1 FY27
Voltas shares (VOLATS) rallied sharply on June 22, 2026, climbing 3.89% to ₹1,419.50 on the NSE after the Tata Group company announced a landmark achievement. Voltas crossed the milestone of selling 1 million air conditioner units within the first three months of FY27, an industry first for the brand in that timeframe. Over the last…
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…